Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD1GK8
|
|||
| Drug Name |
Lumasiran
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Hyperoxaluria [ICD-11: 5C51.2] | Approved | [1] | |
| Company |
Alnylam Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HAO1 messenger RNA (HAO1 mRNA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.